SIGA receives BARDA $26M procurement option exercise for IV TPOXX; deliveries targeted for 2023

SIGA TECHNOLOGIES INC

BARDA exercises procurement options valued at approximately $26M for IV TPOXX under contract 19C.
This is the first procurement option exercise for IV TPOXX under the 19C contract.
Product deliveries of IV TPOXX are targeted for 2023.
Option also funds a post-marketing field study for IV TPOXX.
CEO highlights growing importance of broad orthopox response including monkeypox and smallpox.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.